Showing results (151-160 of 207) with videos related to
Sort By:
Pageof 21
Journal of Clinical Pharmacology|August 1, 1988
Lack of unique ciprofloxacin pharmacokinetic characteristics in patients with cystic fibrosisM D Reed, R C Stern, C M Myers, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 17, 2018
Diabetes associated with immune checkpoint inhibition: presentation and management challengesA Galligan, W Xu, S Fourlanos, et al.Autoimmunity|October 1, 1998
Antibodies to the protein tyrosine phosphatases IAR and IA-2 are associated with progression to insulin-dependent diabetes (IDDM) in first-degree relatives at-risk for IDDMR S Schmidli, P G Colman, L Cui, et al.Chemotherapy|January 1, 1984
Evaluation of latamoxef as initial therapy of bone and joint infections in childhoodS C Aronoff, P V Scoles, M D Reed, et al.Critical Care Medicine|January 1, 1991
Influence of infusion pumps on the pharmacologic response to nitroprussideJ C Hurlbut, S Thompson, M D Reed, et al.Nature Genetics|February 15, 2001
Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B alleleG Morahan, D Huang, S I Ymer, et al.Molecular Medicine (Cambridge, Mass.)|September 1, 1995
Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetesG Rudy, N Stone, L C Harrison, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transportersP D Mozley, J B Stubbs, K Plössl, et al.Antimicrobial Agents and Chemotherapy|November 1, 1983
Efficacy and safety of ceftriaxone in serious pediatric infectionsS C Aronoff, D Murdell, C A O'Brien, et al.The American Journal of Medicine|April 27, 1987
Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosisJ Goldfarb, R C Stern, M D Reed, et al.Pageof 21